Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Ostroff

Showing results (41-50 of 68) with videos related to

Pageof 7
Sort By:
Nature|May 2, 2009
Orally delivered siRNA targeting macrophage Map4k4 suppresses systemic inflammationMyriam Aouadi, Gregory J Tesz, Sarah M Nicoloro, et al.
Journal of Immunology (Baltimore, Md. : 1950)|June 1, 2012
Relative contributions of dectin-1 and complement to immune responses to particulate β-glucansHaibin Huang, Gary R Ostroff, Chrono K Lee, et al.
Plos One|May 7, 2024
A glucan-particle based tularemia subunit vaccine induces T-cell immunity and affords partial protection in an inhalation rat infection modelAdam O Whelan, Helen C Flick-Smith, Nicola J Walker, et al.
Frontiers in Immunology|October 17, 2022
Cross-reactivity between vaccine antigens from the chitin deacetylase protein family improves survival in a mouse model of cryptococcosisMaureen M Hester, Lorena V N Oliveira, Ruiying Wang, et al.
The American Journal of Tropical Medicine and Hygiene|September 14, 2019
<i>Bacillus thuringiensis</i> Cry5B is Active against <i>Strongyloides stercoralis</i> in vitroSarit Charuchaibovorn, Vivornpun Sanprasert, Nataya Sutthanont, et al.
Mbio|December 24, 2015
Protection against Experimental Cryptococcosis following Vaccination with Glucan Particles Containing Cryptococcus Alkaline ExtractsCharles A Specht, Chrono K Lee, Haibin Huang, et al.
Journal of Immunology (Baltimore, Md. : 1950)|July 9, 2004
Mechanism by which orally administered beta-1,3-glucans enhance the tumoricidal activity of antitumor monoclonal antibodies in murine tumor modelsFeng Hong, Jun Yan, Jarek T Baran, et al.
Foods (Basel, Switzerland)|June 2, 2021
Yeast Particle Encapsulation of Scaffolded Terpene Compounds for Controlled Terpene ReleaseErnesto R Soto, Florentina Rus, Hanchen Li, et al.
Mbio|January 28, 2022
Protection of Mice against Experimental Cryptococcosis by Synthesized Peptides Delivered in Glucan ParticlesCharles A Specht, E Jane Homan, Chrono K Lee, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|September 18, 2013
β-Glucan microparticles are good candidates for mucosal antigen delivery in oral vaccinationRebecca De Smet, Tine Demoor, Stephanie Verschuere, et al.
Pageof 7

Showing results (41-50 of 68) with videos related to

Sort By:
Pageof 7
Nature|May 2, 2009
Orally delivered siRNA targeting macrophage Map4k4 suppresses systemic inflammationMyriam Aouadi, Gregory J Tesz, Sarah M Nicoloro, et al.
Journal of Immunology (Baltimore, Md. : 1950)|June 1, 2012
Relative contributions of dectin-1 and complement to immune responses to particulate β-glucansHaibin Huang, Gary R Ostroff, Chrono K Lee, et al.
Plos One|May 7, 2024
A glucan-particle based tularemia subunit vaccine induces T-cell immunity and affords partial protection in an inhalation rat infection modelAdam O Whelan, Helen C Flick-Smith, Nicola J Walker, et al.
Frontiers in Immunology|October 17, 2022
Cross-reactivity between vaccine antigens from the chitin deacetylase protein family improves survival in a mouse model of cryptococcosisMaureen M Hester, Lorena V N Oliveira, Ruiying Wang, et al.
The American Journal of Tropical Medicine and Hygiene|September 14, 2019
<i>Bacillus thuringiensis</i> Cry5B is Active against <i>Strongyloides stercoralis</i> in vitroSarit Charuchaibovorn, Vivornpun Sanprasert, Nataya Sutthanont, et al.
Mbio|December 24, 2015
Protection against Experimental Cryptococcosis following Vaccination with Glucan Particles Containing Cryptococcus Alkaline ExtractsCharles A Specht, Chrono K Lee, Haibin Huang, et al.
Journal of Immunology (Baltimore, Md. : 1950)|July 9, 2004
Mechanism by which orally administered beta-1,3-glucans enhance the tumoricidal activity of antitumor monoclonal antibodies in murine tumor modelsFeng Hong, Jun Yan, Jarek T Baran, et al.
Foods (Basel, Switzerland)|June 2, 2021
Yeast Particle Encapsulation of Scaffolded Terpene Compounds for Controlled Terpene ReleaseErnesto R Soto, Florentina Rus, Hanchen Li, et al.
Mbio|January 28, 2022
Protection of Mice against Experimental Cryptococcosis by Synthesized Peptides Delivered in Glucan ParticlesCharles A Specht, E Jane Homan, Chrono K Lee, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|September 18, 2013
β-Glucan microparticles are good candidates for mucosal antigen delivery in oral vaccinationRebecca De Smet, Tine Demoor, Stephanie Verschuere, et al.
Pageof 7